Avid Bioservices Announces Closing of Public Offering of Common Stock Feb 20, 2018 04:05PM
Avid Bioservices Announces Pricing of Public Offering of Common Stock Feb 15, 2018 05:00AM
Avid Bioservices (CDMO), Oncologie Enter Asset Assignment and Purchase Agreement for Avid's PS-Targeting Program Including Bavituximab Feb 12, 2018 08:14AM
Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including Bavituximab Feb 12, 2018 08:05AM